tirzepatide and eyesight Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Acute onset of neovascular age-related
Description
Thats a drastic change and may feel like a shock to the system
Vessel takes a more
Stay informed with Dignity Weight Center.
In addition, studies in which weight loss was greater during treatment than in the control group and studies in which lifestyle interventions were continued observed significant weight gain after drug discontinuation
These findings suggest that continued physical activity may play a role in preventing weight regain after GLP-1RA discontinuation
